Detalhe da pesquisa
1.
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Cell
; 185(5): 896-915.e19, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35180381
2.
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
Cell
; 184(7): 1858-1864.e10, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33631096
3.
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
Cell
; 184(8): 2201-2211.e7, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743891
4.
COVID-19-neutralizing antibodies predict disease severity and survival.
Cell
; 184(2): 476-488.e11, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412089
5.
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
Cell
; 184(12): 3205-3221.e24, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34015271
6.
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Cell
; 183(1): 169-184.e13, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931734
7.
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19.
Cell
; 183(5): 1340-1353.e16, 2020 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33096020
8.
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
Cell
; 183(4): 996-1012.e19, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010815
9.
Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
Cell
; 183(4): 982-995.e14, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991843
10.
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.
Cell
; 183(7): 1901-1912.e9, 2020 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248470
11.
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Cell
; 183(4): 1024-1042.e21, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991844
12.
BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
Nat Immunol
; 23(1): 33-39, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34848871
13.
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19.
Nat Immunol
; 23(1): 23-32, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937933
14.
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Nat Immunol
; 22(11): 1428-1439, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34471264
15.
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Nat Immunol
; 22(5): 620-626, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674800
16.
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.
Nat Immunol
; 21(10): 1293-1301, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32807944
17.
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.
Cell
; 169(4): 597-609.e11, 2017 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475892
18.
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.
Cell
; 170(2): 273-283.e12, 2017 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28708997
19.
Zika Virus: Immunity and Vaccine Development.
Cell
; 167(3): 625-631, 2016 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27693357
20.
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses.
Immunity
; 54(2): 340-354.e6, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567252